{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:17:47Z","timestamp":1789784267749,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T00:00:00Z","timestamp":1480982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Seventh Framework Programme (BE)","award":["FP7-SME-2013"],"award-info":[{"award-number":["FP7-SME-2013"]}]},{"name":"OxThera Intellectual Property AB, Stockholm, Sweden"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00467-016-3553-8","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T21:25:48Z","timestamp":1481059548000},"page":"781-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["A randomised Phase I\/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria"],"prefix":"10.1007","volume":"32","author":[{"given":"Bernd","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Niaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Harambat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally-Anne","family":"Hulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Van\u2019t Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbir H.","family":"Moochhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Desch\u00eanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sj\u00f6gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,6]]},"reference":[{"key":"3553_CR1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJMra1301564","volume":"369","author":"P Cochat","year":"2013","unstructured":"Cochat P, Rumsby G (2013) Primary hyperoxaluria. N Engl J Med 369:649\u2013658","journal-title":"N Engl J Med"},{"key":"3553_CR2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/BF00711363","volume":"17","author":"CJ Danpure","year":"1994","unstructured":"Danpure CJ, Jennings PR, Fryer P, Purdue PE, Allsop J (1994) Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity. J Inherit Metab Dis 17:487\u2013499","journal-title":"J Inherit Metab Dis"},{"key":"3553_CR3","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ki.2009.32","volume":"75","author":"B Hoppe","year":"2009","unstructured":"Hoppe B, Beck B, Milliner D (2009) The primary hyperoxalurias. Kidney Int 75:1264\u20131271","journal-title":"Kidney Int"},{"key":"3553_CR4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ajhg.2010.07.023","volume":"87","author":"R Belostotsky","year":"2010","unstructured":"Belostotsky R, Seboun E, Idelson Milliner DS, Becker-Cohen R, Rinat C, Monico CG, Feinstein S, Ben-Shalom E, Magen D, Weissman I, Charon C, Frishberg Y (2010) Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Gen 87:392\u2013399","journal-title":"Am J Hum Gen"},{"issue":"Suppl 8","key":"3553_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ndt\/10.supp8.3","volume":"10","author":"P Cochat","year":"1995","unstructured":"Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N (1995) Epidemiology of primary hyperoxaluria type 1. Nephrol Dial Transplant 10[Suppl 8]:3\u20137","journal-title":"Nephrol Dial Transplant"},{"key":"3553_CR6","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/ndt\/10.12.2224","volume":"10","author":"N Kopp","year":"1995","unstructured":"Kopp N, Leumann E (1995) Changing pattern of primary hyperoxaluria in Switzerland. Nephrol Dial Transplant 10:2224\u20132227","journal-title":"Nephrol Dial Transplant"},{"key":"3553_CR7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ndt\/18.2.273","volume":"18","author":"CS Woerden van","year":"2003","unstructured":"van Woerden CS, Groothoff JW, Wanders RJ, Davin JC, Wijburg FA (2003) Primary hyperoxaluria type 1 in the Netherlands: prevalence and outcome. Nephrol Dial Transplant 18:273\u2013279","journal-title":"Nephrol Dial Transplant"},{"key":"3553_CR8","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1681\/ASN.V1291986","volume":"12","author":"E Leumann","year":"2001","unstructured":"Leumann E, Hoppe B (2001) The primary hyperoxalurias. J Am Soc Nephrol 12:1986\u20131993","journal-title":"J Am Soc Nephrol"},{"key":"3553_CR9","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","volume":"26","author":"K Hopp","year":"2015","unstructured":"Hopp K, Cogal AG, Bergstralh EJ, Seide BM, Olson JB, Meek AM, Lieske JC, Milliner DS, Harris PC, Rare Kidney Stone Consortium (2015) Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria. J Am Soc Nephrol 26:2559\u20132570","journal-title":"J Am Soc Nephrol"},{"key":"3553_CR10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrneph.2012.113","volume":"8","author":"B Hoppe","year":"2012","unstructured":"Hoppe B (2012) An update on primary hyperoxaluria. Nat Rev Nephrol 8:467\u2013475","journal-title":"Nat Rev Nephrol"},{"key":"3553_CR11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI63679","volume":"123","author":"SR Mulay","year":"2013","unstructured":"Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, Anders HJ (2013) Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1\u03b2 secretion. J Clin Invest 123:236\u2013246","journal-title":"J Clin Invest"},{"key":"3553_CR12","doi-asserted-by":"crossref","first-page":"FI574","DOI":"10.1152\/ajprenal.00411.2012","volume":"305","author":"E Worcester","year":"2013","unstructured":"Worcester E, Evan A, Coe F, Lingeman J, Krambeck A, Sommers A, Phillips C, Milliner D (2013) A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type 1. Am J Physiol Renal Physiol 305:FI574\u2013584","journal-title":"Am J Physiol Renal Physiol"},{"key":"3553_CR13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ki.2014.298","volume":"87","author":"X Tang","year":"2015","unstructured":"Tang X, Bergstralh EJ, Mehta RA, Vrtiska TJ, Milliner DS, Lieske JC (2015) Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria. Kidney Int 87:623\u2013631","journal-title":"Kidney Int"},{"key":"3553_CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2215\/CJN.02810315","volume":"11","author":"F Zhao","year":"2016","unstructured":"Zhao F, Bergstralh EJ, Mehta RA, Vaughan LE, Olson JB, Seide BM, Meek AM, Cogal AG, Lieske JC, Milliner DS, Investigators of the Rare Kidney Stone Consortium (2016) Predictors of incident ESRD among patients with primary hyperoxaluria presenting prior to kidney failure. Clin J Am Soc Nephrol 11:119\u2013126","journal-title":"Clin J Am Soc Nephrol"},{"key":"3553_CR15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000086360","volume":"25","author":"JC Lieske","year":"2005","unstructured":"Lieske JC, Monico CG, Holmes WS, Bergstralh EJ, Slezak JM, Rohlinger AL, Olson JB, Milliner DS (2005) International registry for Primary Hyperoxaluria. Am J Nephrol 25:290\u2013296","journal-title":"Am J Nephrol"},{"key":"3553_CR16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ki.2009.435","volume":"77","author":"J Harambat","year":"2010","unstructured":"Harambat J, Fargue S, Acquaviva C, Gagnadoux MF, Janssen F, Liutkus A, Mourani C, Macher MA, Abramowicz D, Legendre C, Durrbach A, Tsimaratos M, Nivet H, Girardin E, Schott AM, Rolland MO, Cochat P (2010) Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int 77:443\u2013449","journal-title":"Kidney Int"},{"key":"3553_CR17","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/ndt\/gfs078","volume":"27","author":"P Cochat","year":"2012","unstructured":"Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, Fargue S, Groothoff J, Harambat J, Hoppe B, Jamieson NV, Kemper MJ, Mandrile G, Marangella M, Picca S, Rumsby G, Salido E, Straub M, van Woerden CS (2012) Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant 27:1729\u20131736","journal-title":"Nephrol Dial Transplant"},{"key":"3553_CR18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1046\/j.1523-1755.1998.00066.x","volume":"54","author":"B Hoppe","year":"1998","unstructured":"Hoppe B, Kemper MJ, B\u00f6kenkamp A, Langman CB (1998) Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria. Kidney Int 54:921\u2013925","journal-title":"Kidney Int"},{"key":"3553_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/13543784.2013.741587","volume":"22","author":"BB Beck","year":"2014","unstructured":"Beck BB, Hoyer-Kuhn H, G\u00f6bel H, Habbig S, Hoppe B (2014) Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions. Expert Opin Invest Drugs 22:117\u2013129","journal-title":"Expert Opin Invest Drugs"},{"key":"3553_CR20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ki.2009.237","volume":"76","author":"S Fargue","year":"2009","unstructured":"Fargue S, Harambat J, Gagnadoux MF, Tsimaratos M, Janssen F, Llanas B, Berth\u00e9l\u00e9m\u00e9 JP, Boudailliez B, Champion G, Guyot C, Macher MA, Nivet H, Ranchin B, Salomon R, Taque S, Rolland MO, Cochat P (2009) Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1. Kidney Int 76:767\u2013773","journal-title":"Kidney Int"},{"key":"3553_CR21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2215\/CJN.06820613","volume":"9","author":"H Hoyer-Kuhn","year":"2014","unstructured":"Hoyer-Kuhn H, Kohbrok S, Volland R, Franklin J, Hero B, Beck BB, Hoppe B (2014) Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice. Clin J Am Soc Nephrol 9:468\u2013477","journal-title":"Clin J Am Soc Nephrol"},{"key":"3553_CR22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AEM.40.4.833-839.1980","volume":"40","author":"KA Dawson","year":"1980","unstructured":"Dawson KA, Allison MJ, Hartman PA (1980) Isolation and some characteristics of anaerobic oxalate degrading bacteria from the rumen. Appl Environ Microbiol 40:833\u2013839","journal-title":"Appl Environ Microbiol"},{"key":"3553_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00446731","volume":"141","author":"MJ Allison","year":"1985","unstructured":"Allison MJ, Dawson KA, Mayberry WR, Foss JG (1985) Oxalobacter formigenes gen. nov. sp.nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141:1\u20137","journal-title":"Arch Microbiol"},{"key":"3553_CR24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/end.2010.0462","volume":"25","author":"JP Kelly","year":"2011","unstructured":"Kelly JP, Curhan GC, Cave DR, Anderson TE, Kaufman DW (2011) Factors related to colonization with Oxalobacter formigenes in U.S. Adults. J Endourol 25:673\u2013679","journal-title":"J Endourol"},{"key":"3553_CR25","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1681\/ASN.2011040433","volume":"22","author":"F Knauf","year":"2011","unstructured":"Knauf F, Lo N, Jiang Z, Robertson WG, van Italie CM, Anderson JM, Aronson PS (2011) Net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion. J Am Soc Nephrol 22:2247\u20132255","journal-title":"J Am Soc Nephrol"},{"key":"3553_CR26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00240-013-0601-8","volume":"41","author":"M Hatch","year":"2013","unstructured":"Hatch M, Freel RW (2013) A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion. Urolithiasis 41:379\u2013384","journal-title":"Urolithiasis"},{"key":"3553_CR27","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.ki.5001707","volume":"70","author":"B Hoppe","year":"2006","unstructured":"Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1305\u20131311","journal-title":"Kidney Int"},{"key":"3553_CR28","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1093\/ndt\/gfr107","volume":"26","author":"B Hoppe","year":"2011","unstructured":"Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Desch\u00eanes G, Unwin R, Milliner D (2011) Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant 26:3609\u20133615","journal-title":"Nephrol Dial Transplant"},{"key":"3553_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0009-8981(82)90080-8","volume":"120","author":"BG Wolthers","year":"1982","unstructured":"Wolthers BG, Hayer M (1982) The determination of oxalic acid in plasma and urine by means of capillary gas chromatography. Clin Chim Acta 120:87\u2013102","journal-title":"Clin Chim Acta"},{"key":"3553_CR30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00240-016-0860-2","volume":"44","author":"O Clifford-Mobley","year":"2016","unstructured":"Clifford-Mobley O, Sj\u00f6gren A, Lindner E, Rumsby G (2016) Urine oxalate biological variation in patients with primary hyperoxaluria. Urolithiasis 44:333\u2013337","journal-title":"Urolithiasis"},{"key":"3553_CR31","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/ard.2006.060368","volume":"66","author":"E Pascual","year":"2007","unstructured":"Pascual E, Sivera F (2007) Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout. Ann Rheum Dis 66:1056\u20131058","journal-title":"Ann Rheum Dis"},{"key":"3553_CR32","unstructured":"Lagies R, Herberg U, Hoppe B, Feldkoetter M, Udink ten Cate F, Beck B (2015) Speckle Tracking Echocardiography detects impaired systolic function in patients with primary hyperoxaluria type I. Nieren und Hochdruckkrankheiten 44(2):74 (abstract 57)"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3553-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-016-3553-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3553-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T12:28:24Z","timestamp":1657974504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-016-3553-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,6]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["3553"],"URL":"https:\/\/doi.org\/10.1007\/s00467-016-3553-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,6]]}}}